CHEMOMAB THERAPEUTICS LTD's ticker is CMMB and the CUSIP is 16385C104. A total of 13 filers reported holding CHEMOMAB THERAPEUTICS LTD in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $129,000 | -22.8% | 35,024 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $167,000 | -35.5% | 35,024 | -6.8% | 0.00% | -50.0% |
| Q4 2021 | $259,000 | -37.7% | 37,567 | 0.0% | 0.00% | -42.9% |
| Q3 2021 | $416,000 | -73.1% | 37,567 | -53.8% | 0.01% | -65.0% |
| Q2 2021 | $1,546,000 | +546.9% | 81,328 | +878.6% | 0.02% | +185.7% |
| Q1 2021 | $239,000 | – | 8,311 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 268,104 | $992,000 | 0.18% |
| Orbimed Advisors | 2,578,174 | $9,539,000 | 0.17% |
| Cormorant Asset Management, LP | 288,168 | $1,066,000 | 0.08% |
| Urban Wealth Management, LLC | 2,762 | $10,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 41,300 | $153,000 | 0.00% |
| MEITAV INVESTMENT HOUSE LTD | 35,024 | $129,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 1,100 | $4,000 | 0.00% |
| ENVESTNET ASSET MANAGEMENT INC | 12,193 | $45,000 | 0.00% |
| ROYAL BANK OF CANADA | 248 | $1,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 7,728 | $29,000 | 0.00% |